NM_001753.5:c.196-1421G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001753.5(CAV1):​c.196-1421G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.278 in 151,964 control chromosomes in the GnomAD database, including 6,116 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.28 ( 6116 hom., cov: 32)

Consequence

CAV1
NM_001753.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.16

Publications

6 publications found
Variant links:
Genes affected
CAV1 (HGNC:1527): (caveolin 1) The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]
CAV1 Gene-Disease associations (from GenCC):
  • pulmonary arterial hypertension
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pulmonary hypertension, primary, 3
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital generalized lipodystrophy type 3
    Inheritance: AD, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
  • heritable pulmonary arterial hypertension
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Berardinelli-Seip congenital lipodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.36 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAV1NM_001753.5 linkc.196-1421G>A intron_variant Intron 2 of 2 ENST00000341049.7 NP_001744.2
CAV1NM_001172895.1 linkc.103-1421G>A intron_variant Intron 2 of 2 NP_001166366.1
CAV1NM_001172896.2 linkc.103-1421G>A intron_variant Intron 1 of 1 NP_001166367.1
CAV1NM_001172897.2 linkc.103-1421G>A intron_variant Intron 2 of 2 NP_001166368.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAV1ENST00000341049.7 linkc.196-1421G>A intron_variant Intron 2 of 2 1 NM_001753.5 ENSP00000339191.2

Frequencies

GnomAD3 genomes
AF:
0.278
AC:
42146
AN:
151846
Hom.:
6114
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.365
Gnomad AMI
AF:
0.280
Gnomad AMR
AF:
0.228
Gnomad ASJ
AF:
0.249
Gnomad EAS
AF:
0.220
Gnomad SAS
AF:
0.261
Gnomad FIN
AF:
0.276
Gnomad MID
AF:
0.248
Gnomad NFE
AF:
0.243
Gnomad OTH
AF:
0.262
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.278
AC:
42188
AN:
151964
Hom.:
6116
Cov.:
32
AF XY:
0.276
AC XY:
20509
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.365
AC:
15117
AN:
41416
American (AMR)
AF:
0.228
AC:
3483
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.249
AC:
862
AN:
3468
East Asian (EAS)
AF:
0.220
AC:
1136
AN:
5166
South Asian (SAS)
AF:
0.260
AC:
1254
AN:
4822
European-Finnish (FIN)
AF:
0.276
AC:
2912
AN:
10534
Middle Eastern (MID)
AF:
0.253
AC:
74
AN:
292
European-Non Finnish (NFE)
AF:
0.243
AC:
16548
AN:
67974
Other (OTH)
AF:
0.259
AC:
547
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1523
3046
4569
6092
7615
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
426
852
1278
1704
2130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.224
Hom.:
1651
Bravo
AF:
0.279
Asia WGS
AF:
0.219
AC:
766
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.094
DANN
Benign
0.68
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3807994; hg19: chr7-116197579; API